Perimenopause and GLP-1 medicines can both change your sleep, appetite, mood and periods. Here is how to tell what might be causing what, and what to track for your doctor.
Many women start a GLP-1 in their 40s and 50s, right when perimenopause is shifting things too. So when something changes, the natural question is: is it the medication or my hormones? Often the honest answer is “possibly both”. Here’s how to think it through.
Perimenopause is the transition before your final period, and it can last several years. Common signs include:
Menopause itself is confirmed after 12 months without a period.
GLP-1 medicines most commonly cause stomach side effects: nausea, constipation, diarrhea and reduced appetite. These tend to be strongest when you start or increase your dose. Fatigue is also listed on both the Wegovy and Zepbound labels.
So a rough week of low energy, poor appetite and bad sleep could come from a recent dose increase, a perimenopause flare, or both.
Many women on a GLP-1 are also using or considering HRT. According to Eli Lilly’s medical information, there is no data on tirzepatide combined with oral hormone therapy, because it hasn’t been studied. Patches and gels are absorbed through the skin, not the stomach. Ask your prescriber which form makes sense for you.
A few seconds a day builds a picture your doctor can act on:
Bring a one-page summary to your appointment. “My night sweats got worse two months before my dose went up” is much easier to act on than “I haven’t felt great.”
Here’s what a simple log might show for someone on a weekly Sunday shot:
| Day | Dose | Nausea | Sleep | Night sweats | Hot flashes |
|---|---|---|---|---|---|
| Sun | 5 mg | – | OK | No | 1 |
| Mon | Moderate | Poor | Yes | 3 | |
| Tue | Mild | Poor | Yes | 4 | |
| Wed–Sat | – | OK | Some | 2–3 |
A pattern like this can suggest the nausea follows the shot, while the sweats and flashes happen on their own schedule. Three or four weeks of logs make the pattern much clearer, for you and your doctor.
Midlife is when many women notice weight becomes harder to manage, often around perimenopause, and it’s also when many start a GLP-1. So two big changes often land at once. Neither cancels out the other. The GLP-1 doesn’t treat hot flashes, and perimenopause doesn’t make the medicine less important. Treating them as two separate things to track helps.
Whatever the cause, don’t wait to mention:
Try:
“I started [medication] in [month] and I’m also noticing [symptoms]. I’ve tracked them for [X] weeks. Can we look at what might be the shot and what might be perimenopause?”
A one-page summary of doses, cycle and symptoms turns a 10-minute appointment into a useful one.
Hot flashes aren’t a common GLP-1 side effect on the labels. They’re a classic perimenopause symptom, so it’s worth tracking them and mentioning them to your doctor.
There isn’t good evidence either way yet. Your prescriber can review your progress and your symptoms together.
Ideally both should know the full picture. Bring the same summary to each appointment.